BACHI Competitors

Honeywell is a Fortune 500 company that invents and manufactures technologies to address tough challenges linked to global macrotrends such as safety, security, and energy. With approximately 110,000 employees worldwide, including more than 19,000 engineers and scientists, we have an unrelenting focus on quality, delivery, value, and technology in everything we make and do. For additional information on how Honeywell processes your personal information please visit https://www.honeywell.com/privacy-statement.

The need for energy is universal. That's why ExxonMobil scientists and engineers are pioneering new research and pursuing new technologies to reduce emissions while creating more efficient fuels. We're committed to responsibly meeting the world's energy needs. We aim to achieve #netzero emissions from our operated assets by 2050 (for Scope 1 and 2 greenhouse gas emissions) and are taking a comprehensive approach to create emission-reduction roadmaps for major operated assets. Find us also on: YouTube.com/ExxonMobil Find our latest Privacy Policy at https://corporate.exxonmobil.com/Global-legal-pages/privacy-policy See our terms and conditions at https://corporate.exxonmobil.com/global-legal-pages/terms-and-conditions Find resources on our GHG emission reduction efforts here: https://corporate.exxonmobil.com/resources

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines. Our Purpose is to push the boundaries of science to deliver life-changing medicines. We believe the best way we can achieve our Purpose is to put science at the centre of everything we do. Science defines who we are. It is why we come to work every day and is part of our DNA. But this is only half of the story. We know that we do not have all the answers. We want to share ideas because we believe it results in better medicines. We want the way we work to be inclusive, open and collaborative. This approach runs through all that we do. We focus on three main therapy areas – Oncology, Cardiovascular & Metabolic Disease (CVMD) and Respiratory – and we are also selectively active in the areas of autoimmunity, neuroscience and infection. To put ourselves in the best position to push the boundaries of science, we seek to leverage our combination of capabilities, which encompass both small molecules and biologics, and include immunotherapies and developing innovative delivery devices that can offer choice to patients. These are reinforced by a strong focus on personalised healthcare capabilities, which aim to match medicines only to those patients who will benefit from them. Our teams also work alongside the world's leading academic and biotech research institutions to stimulate innovation and evaluate emerging technologies such as Modified RNA and CRISPR genome editing. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information, visit www.astrazeneca.com. Community Guidelines: bit.ly/2MgAcio